Company Overview
X4 PHARMACEUTICALS, INC
XFORRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
35M
2025 FY
Net Income
-79M
2025 FY
Shares Outstanding
42M
2025 FY
EPS
-1.87USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1501697
Exchange
Nasdaq
Location
US